Severe IgE-mediated cow's milk allergy research hub

Prospective, open-label study to analyze the efficacy and safety of low-dose oral immunotherapy in children with severe IgE-mediated cow's milk allergy treated with omalizumab. ILO study.

This study is looking at a new way to treat children with a severe cow's milk allergy. It combines a special medicine called Xolair with small, increasing amounts of cow's milk to see if it can help children safely eat milk products.